SCHEMBL21717042

SCHEMBL21717042

c1ccc(-c2nc3ccccc3nc2-c2ccc3cc(-n4c5ccc(-n6c7ccccc7c7cc8ccccc8cc76)cc5c5cc6ccccc6cc54)ccc3c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.38
LMNA P02545 3/20 0.38
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
THRB P10828 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
GAA P10253 1/20 0.38
NPY5R Q15761 1/20 0.37
POLB P06746 1/20 0.36
HSD17B10 Q99714 1/20 0.36
HPGD P15428 2/20 0.36
ATM Q13315 1/20 0.36
RAC2 P15153 1/20 0.35
RAC3 P60763 1/20 0.35
CDC42 P60953 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21716813 1.00 L3MBTL1 (0.38) L3MBTL1LMNAKDM4EALDH1A1TDP1
SCHEMBL21717050 0.97 ADORA2A (0.38) L3MBTL1LMNAKDM4EALDH1A1TDP1
SCHEMBL21716450 0.97 ADORA2A (0.38) L3MBTL1LMNAKDM4EALDH1A1TDP1
SCHEMBL21717048 0.95 HPGD (0.37) L3MBTL1KDM4EALDH1A1ADORA2AADORA1
SCHEMBL21716806 0.95 HPGD (0.37) L3MBTL1KDM4EALDH1A1ADORA2AADORA1
SCHEMBL21717041 0.94 HTR6 (0.34) L3MBTL1LMNAKDM4EALDH1A1TDP1
SCHEMBL21716714 0.94 MAPK10 (0.36) L3MBTL1LMNAKDM4EALDH1A1TDP1
SCHEMBL21716214 0.94 MAPK10 (0.36) L3MBTL1LMNAKDM4EALDH1A1TDP1
SCHEMBL21716216 0.94 L3MBTL1 (0.41) L3MBTL1LMNAKDM4EALDH1A1TDP1
SCHEMBL21716715 0.94 L3MBTL1 (0.41) L3MBTL1LMNAKDM4EALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-12-07 US disclosed
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same CYP1A1, CYP1B1, CRY1 L3MBTL1 1427/4885LMNA 2047/4885KDM4E 1813/4885
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1A1, CYP1B1, CRY1 L3MBTL1 1427/4885LMNA 2047/4885KDM4E 1813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.